CNBC Squawk Box November 17, 2014
Stories this morning. Deal news dominating this morning. Valeant ends the buyout deal for allergan. They made an unsolicited deal last spring. It looks like the soap opera could end, 210 is more than they expected. Hackman and valeant are going to share the profits that ackman has reportedly made with the stock at 40 . This is a winwin situation because of the way he structured this. But valeant shareholders effectively split the profits with ackman. With the purchase there. Thats pretty interesting. We will see what they can do. I think that 210 is sort of a knockout blow. But because the exp...